Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.30
    +0.57 (+0.69%)
     
  • GOLD

    2,409.20
    +11.20 (+0.47%)
     
  • Bitcoin AUD

    100,276.27
    +1,676.22 (+1.70%)
     
  • CMC Crypto 200

    1,382.49
    +69.87 (+5.32%)
     
  • AUD/EUR

    0.6025
    -0.0006 (-0.10%)
     
  • AUD/NZD

    1.0904
    +0.0029 (+0.27%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,030.67
    -363.65 (-2.09%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,942.61
    +167.23 (+0.44%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

1 Top Biotech Stock Ready for a Bull Run

1 Top Biotech Stock Ready for a Bull Run

The road to FDA approval can be long, and in the case of COVID-19 vaccines, there is no time for delays and no room for error. One company that has come to understand this very well is Novavax (NASDAQ: NVAX). Since 2020, the company has been developing a vaccine to help prevent and fight the impact of COVID-19.